Aardvark Therapeutics, Inc. SEC filings AARD
Aardvark Therapeutics, Inc. has 114 filings in SEC EDGAR's recent list, going back to May 24, 2019. Its latest annual report, Form ARS, was filed on Jul 10, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 11, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 23, 2026 (other events). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 4 | Insider transaction | Oct 8, 2026 | Oct 7, 2026 |
| 3 | Initial insider ownership | Oct 8, 2026 | Oct 7, 2026 |
| 4 | Insider transaction | Sep 11, 2026 | Sep 10, 2026 |
| 144 | Notice of proposed sale | Sep 11, 2026 | — |
| 144 | Notice of proposed sale | Sep 10, 2026 | — |
| 4 | Insider transaction | Aug 21, 2026 | Aug 14, 2026 |
| 4 | Insider transaction | Aug 21, 2026 | Aug 14, 2026 |
| 4 | Insider transaction | Aug 21, 2026 | Aug 14, 2026 |
| 4 | Insider transaction | Aug 21, 2026 | Aug 14, 2026 |
| 4 | Insider transaction | Feb 11, 2026 | Feb 9, 2026 |
| 4 | Insider transaction | Feb 11, 2026 | Feb 9, 2026 |
| 4 | Insider transaction | Feb 11, 2026 | Feb 9, 2026 |
| 4 | Insider transaction | Dec 12, 2025 | Dec 11, 2025 |
| 4 | Insider transaction | Dec 12, 2025 | Dec 11, 2025 |
| 4 | Insider transaction | Oct 16, 2025 | Oct 15, 2025 |
| 4 | Insider transaction | Oct 16, 2025 | Oct 15, 2025 |
| 4 | Insider transaction | Sep 16, 2025 | Sep 15, 2025 |
| 144 | Notice of proposed sale | Sep 15, 2025 | — |
| 4 | Insider transaction | Sep 12, 2025 | Sep 10, 2025 |
| 4 | Insider transaction | Sep 10, 2025 | Sep 9, 2025 |
| 144 | Notice of proposed sale | Sep 2, 2025 | — |
| 4 | Insider transaction | Aug 29, 2025 | Aug 28, 2025 |
| 144 | Notice of proposed sale | Aug 28, 2025 | — |
| 4 | Insider transaction | Jun 13, 2025 | Jun 11, 2025 |
| 4 | Insider transaction | Jun 13, 2025 | Jun 11, 2025 |
| 4 | Insider transaction | Jun 13, 2025 | Jun 11, 2025 |
| 4 | Insider transaction | Jun 13, 2025 | Jun 11, 2025 |
| 4 | Insider transaction | Jun 13, 2025 | Jun 11, 2025 |
| 4 | Insider transaction | Jun 13, 2025 | Jun 11, 2025 |
| 4 | Insider transaction | Jun 13, 2025 | Jun 11, 2025 |
| 4 | Insider transaction | Jun 13, 2025 | Jun 11, 2025 |
| SCHEDULE 13G | Ownership over 5% (passive) | May 15, 2025 | — |
| SCHEDULE 13G | Ownership over 5% (passive) | Feb 24, 2025 | — |
| SCHEDULE 13G | Ownership over 5% (passive) | Feb 24, 2025 | — |
| SCHEDULE 13G | Ownership over 5% (passive) | Feb 24, 2025 | — |
| 4 | Insider transaction | Feb 19, 2025 | Feb 14, 2025 |
| 4 | Insider transaction | Feb 19, 2025 | Feb 14, 2025 |
| 4 | Insider transaction | Feb 19, 2025 | Feb 14, 2025 |
| 4 | Insider transaction | Feb 19, 2025 | Feb 14, 2025 |
| 4 | Insider transaction | Feb 19, 2025 | Feb 14, 2025 |
| 4 | Insider transaction | Feb 19, 2025 | Feb 14, 2025 |
| 3 | Initial insider ownership | Feb 12, 2025 | Feb 12, 2025 |
| 3 | Initial insider ownership | Feb 12, 2025 | Feb 12, 2025 |
| 3 | Initial insider ownership | Feb 12, 2025 | Feb 12, 2025 |
| 3 | Initial insider ownership | Feb 12, 2025 | Feb 12, 2025 |
| 3 | Initial insider ownership | Feb 12, 2025 | Feb 12, 2025 |
| 3 | Initial insider ownership | Feb 12, 2025 | Feb 12, 2025 |
| 3 | Initial insider ownership | Feb 12, 2025 | Feb 12, 2025 |
| 3 | Initial insider ownership | Feb 12, 2025 | Feb 12, 2025 |
| 3 | Initial insider ownership | Feb 12, 2025 | Feb 12, 2025 |
| 3 | Initial insider ownership | Feb 12, 2025 | Feb 12, 2025 |
| 3 | Initial insider ownership | Feb 12, 2025 | Feb 12, 2025 |
Showing 52 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- AARD (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- San Diego, CA
- SEC filer status
- , Emerging growth company
- SEC CIK
- 1774857
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.